Attached files
| file | filename |
|---|---|
| EX-32.2 - ProPhase Labs, Inc. | ex32-2.htm |
| EX-32.1 - ProPhase Labs, Inc. | ex32-1.htm |
| EX-31.2 - ProPhase Labs, Inc. | ex31-2.htm |
| EX-31.1 - ProPhase Labs, Inc. | ex31-1.htm |
| EX-23.2 - ProPhase Labs, Inc. | ex23-2.htm |
| EX-23.1 - ProPhase Labs, Inc. | ex23-1.htm |
| EX-10.18 - ProPhase Labs, Inc. | ex10-18.htm |
| 10-K - ProPhase Labs, Inc. | form10-k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF PROPHASE LABS, INC.
| State or other | ||||||
| Jurisdiction of | Ownership | |||||
| Subsidiaries | Incorporation | Percentage | ||||
| Pharmaloz Manufacturing Inc. | Delaware | 100 | % | |||
| Phusion Labs Manufacturing, Inc. | Delaware | 100 | % | |||
| ProPhase Digital Media, Inc. | Delaware | 100 | % | |||
| ProPhase Diagnostics, Inc. | Delaware | 100 | % | |||
| ProPhase Diagnostics NJ, Inc. | New York | 100 | % | |||
| ProPhase Diagnostics NY, Inc. | Delaware | 100 | % | |||
| Quigley Pharma Inc. | Delaware | 100 | % | |||
| TK Supplements, Inc. | Delaware | 100 | % | |||
The above subsidiaries are included in the consolidated financial statements for the year ended December 31, 2020.